| Prev Close | 47.21 |
| Open | 48.27 |
| Day Low/High | 48.16 / 56.40 |
| 52 Wk Low/High | 12.71 / 49.55 |
| Volume | 5.88M |
Halozyme Therapeutics, Inc. (HALO)
54.92
7.70
16.00
NASDAQ
| Exchange | NASDAQ |
| Shares Outstanding | 135.18B |
| Market Cap | 6.58B |
| P/E Ratio | 309.38 |
| Div & Yield | N.A. (N.A) |
Latest News
2 Stocks You Definitely Should Consider Shorting This Week
These 'Bearish Bets' are showing both technical and quantitative deterioration.
Sage Therapeutics Skyrockets on Data for Depression Drug -- Biotech Movers
The Cambridge, Mass.-based firm unveiled positive top-line results from its Phase 2 study of SAGE-217 in patients with moderate to severe major depressive disorder.
Spectrum Shares Surge on Data for Lung Cancer Drug -- Biotech Movers
The Henderson, Nev.-based company said interim data from a Phase 2 study showed an objective response rate of 73%.
Shark Bites: Market Starts Selling the News Even Before Trump Talks Taxes
Proposals are having an effect ahead of afternoon announcement.
Strong Action in Individual Stocks Starts to Feel a Bit Frothy
It's hard to predict when momentum will slow, but it could be time to take some profits when the market is as strong as this morning.
Good Stocks Are There for the Picking
Focus on what could go right.
There Are Good Opportunities in Stock Picking
The indices may need a rest, but stock-pickers have an edge.
Slowly but Surely, Post-Fed Euphoria Dissipates
The market response to the Fed was quite extreme, although there really wasn't any major development.
Are Your Stocks Just Running in Place?
If investing is like a horserace, you can change horses in the middle of the race.
Bullish & Bearish Reversals for the Week
Energy and consumer defensive names dominate on the bearish side.
Netflix Can Break out Soon
Plus, charts from ALGN, HALO and CME.
Biotech: Partnerships Spell Success
Bet on small-caps with big-name collaborators.
So-So Start, But GoPro Is Going Higher
The market is off to a tepid start after rallying for three straight days -- certainly understandable, and some profit taking should be expected as we trade up near the highs of the relatively narrow trading range that has existed throughout most of...
Playing Biotechs with the House's Money
Here's how to lock in gains on risky small-cap biotechnology stocks.
Market Gains Steam
Stocks have gotten stronger since our last update, as the S&P 500 and DJIA have joined the Nasdaq in positive territory. Oil is giving back a little of its recent gains. One can see how lower jet fuel costs are bolstering airline earnings. Fuel cost...
Partnerships Lift Small Caps
Watch for small biotechs partnering with bigger firms.
Premarket Musings
As always, it is my pleasure to be filling in for Doug Kass on the Daily Diary today. Earnings reports will continue to flow in as we are in the heart of first-quarter earnings seasons, which, as usual, is coming in a little better than expectations...
How I Play the Biotechs
A strategy to immunize biotech investors from regret.
Biotech Stocks at a Crossroad
Own them, or take something off the table?
Take Aim at Threshold Pharmaceuticals
A small biotech gem with lots of potential.
The Next Biotech Breakout?
As always, I am happy to be standing in for Doug Kass today on the Daily Diary (this Friday from sunny Miami). It looks like it will be an up open to talk about based on early market futures. The euro is heading towards its best week in 18 months, e...
Small-Cap Focus: Navidea
Aggressive investors should look at a small speculative position.
Biotechs Enliven Familiar Pattern
Buying was more sedate than it has been.
A Steady but Sloppy Day
Awaiting Yellen, but some churn wouldn't hurt.
Small-Cap Friday's Little Gem
One small pharmaceutical company has big potential.
The Trend Is Up
Fighting this market isn't a money maker.
Two Small-Cap Biotechs To Consider
Fibrocell Science and Prothena have several 'shots on goal.'
Where's the Worry?
It may not feel intuitive to embrace this market, but it works.
